Advertisement
UK markets open in 8 minutes
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,726.43
    +441.89 (+2.56%)
     
  • CRUDE OIL

    83.93
    +0.36 (+0.43%)
     
  • GOLD FUTURES

    2,351.90
    +9.40 (+0.40%)
     
  • DOW

    38,085.80
    -375.12 (-0.98%)
     
  • Bitcoin GBP

    51,521.02
    +161.90 (+0.32%)
     
  • CMC Crypto 200

    1,390.86
    -5.67 (-0.41%)
     
  • NASDAQ Composite

    15,611.76
    -100.99 (-0.64%)
     
  • UK FTSE All Share

    4,387.94
    +13.88 (+0.32%)
     

Here's Why Moderna's Growth May Be Just Getting Started

Here's Why Moderna's Growth May Be Just Getting Started

Moderna (NASDAQ: MRNA) stock might look a bit expensive these days. At the same time, some investors wonder whether Moderna may have reached peak sales of its coronavirus vaccine. Right now, it's too early to predict if and when coronavirus vaccine sales will slow.